Recent advances now permit resection of many pharyngeal tumors through the open mouth, an approach that can greatly reduce the morbidity of surgical exposure. These transoral techniques are being rapidly adopted by the surgical community and hold considerable promise. On November 6-7, 2011, the National Cancer Institute sponsored a Clinical Trials Planning Meeting to address how to further investigate the use of transoral surgery, both in the good prognosis human papillomavirus (HPV)-initiated oropharyngeal cancers, and in those with HPV-unrelated disease. The proceedings of this meeting are summarized. Copyright 2012 Wiley Periodicals, Inc.
ContributorsAdelstein, David J. Ridge, John A. Brizel, David M. Holsinger, F. Christopher Haughey, Bruce H. O'Sullivan, Brian Genden, Eric M. Beitler, Jonathan J. Weinstein, Gregory S. Quon, Harry Chepeha, Douglas B. Ferris, Robert L. Weber, Randal S. Movsas, Benjamin Waldron, John Lowe, Val Ramsey, Scott Manola, Judith Yueh, Bevan Carey, Thomas E. Bekelman, Justin E. Konski, Andre A. Moore, Eric Forastiere, Arlene Schuller, David E. Lynn, Jean Ullmann, Claudio Dansky
Disease Category: Cancer
Disease Name: Head and neck cancer
Age Range: Unknown
Sex: Either
Nature of Intervention: Surgery
- Clinical experts
- Other
- Study investigators
- COS for clinical trials or clinical research
- Semi structured discussion
Semi structured discussion: meeting